Vidal-Cortés P, Díaz Santos E, Aguilar Alonso E, Amezaga Menéndez R, Ballesteros M Á, Bodí M A, Bordejé Laguna M L, Garnacho Montero J, García Sánchez M, López Sánchez M, Martín-Loeches I, Ochagavía Calvo A, Ramírez Galleymore P, Alcántara Carmona S, Andaluz Ojeda D, Badallo Arébalo O, Barrasa González H, Borges Sa M, Castellanos-Ortega Á, Estella Á, Ferrer Roca R, Fraile Gutiérrez V, Fuset Cabanes M, Giménez-Esparza Vich C, González Iglesias C, Hernández-Tejedor A, Igeño Cano J C, Iglesias Posadilla D, Jiménez Rivera J J, Llanos Jorge C, Llompart-Pou J A, López Camps V, Lorencio Cárdenas C, Marcos Neira P, Martín Delgado M C, Martín-Macho González M, Martín Villén L, Nuvials Casals X, Ortiz Suñer A, Quintana Díaz M, Rascado Sedes P, Recuerda Núñez M, Del Río Carbajo L, Rodríguez Aguirregabiria M, Rodríguez Oviedo A, Seijas Betolaza I, Soriano Cuesta C, Suberviola Cañas B, Vera Ching C, Vidal González Á, Zapata Fenor L, Zaragoza Crespo R
Medicina Intensiva, Complexo Hospitalario Universitario de Ourense, Ourense, España.
Medicina Intensiva, Consorci Corporació Sanitaria Parc Taulí, Sabadell, España.
Med Intensiva. 2022 Feb;46(2):81-89. doi: 10.1016/j.medin.2021.08.011. Epub 2021 Sep 16.
The COVID-19 pandemic has led to the admission of a high number of patients to the ICU, generally due to severe respiratory failure. Since the appearance of the first cases of SARS-CoV-2 infection, at the end of 2019, in China, a huge number of treatment recommendations for this entity have been published, not always supported by sufficient scientific evidence or with methodological rigor necessary. Thanks to the efforts of different groups of researchers, we currently have the results of clinical trials, and other types of studies, of higher quality. We consider it necessary to create a document that includes recommendations that collect this evidence regarding the diagnosis and treatment of COVID-19, but also aspects that other guidelines have not considered and that we consider essential in the management of critical patients with COVID-19. For this, a drafting committee has been created, made up of members of the SEMICYUC Working Groups more directly related to different specific aspects of the management of these patients.
新冠疫情导致大量患者因严重呼吸衰竭入住重症监护病房（ICU）。自2019年底中国出现首例严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染病例以来，针对该疾病已发布了大量治疗建议，但这些建议并不总是有充分的科学证据支持，也缺乏必要的方法严谨性。得益于不同研究团队的努力，我们目前拥有了更高质量的临床试验及其他类型研究的结果。我们认为有必要创建一份文件，其中包含收集到的关于新冠病毒病（COVID-19）诊断和治疗的证据建议，还包括其他指南未考虑但我们认为在管理COVID-19重症患者中至关重要的方面。为此，成立了一个起草委员会，其成员来自与这些患者管理不同具体方面更直接相关的西班牙重症监护和心肺复苏学会（SEMICYUC）工作组。
